Russell C Callaghan
Overview
Explore the profile of Russell C Callaghan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
916
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clay J, Callaghan R, Sherk A, Naimi T, Stockwell T, Asbridge M
Drug Alcohol Rev
. 2024 Dec;
44(2):434-447.
PMID: 39667732
Introduction: Alcohol contributes significantly to global disease burden. Over 50 countries, including Canada, have established low-risk drinking guidelines to reduce alcohol-related harm. Canada's Guidance on Alcohol and Health (CGAH) was...
2.
Callaghan R, Sanches M, Hathaway A, Asbridge M, Kish S
Addict Behav
. 2023 Jul;
146:107813.
PMID: 37515896
Background And Aim: A central goal of the Cannabis Act (October 17, 2018) - Canada's national cannabis legalization framework - aimed to reduce cannabis-related criminalization and consequent impact on the...
3.
Callaghan R, Sanches M, Hathaway A, Asbridge M, MacDonald M, Kish S
Drug Alcohol Depend
. 2023 May;
258:109892.
PMID: 37183068
Background: We previously reported that the 2018 Canadian Cannabis Act, allowing youth to possess up to 5 g dried cannabis or equivalent for personal use/sharing, was associated with short-term (76...
4.
Callaghan R, Sanches M, Vander Heiden J, Kish S
Drug Alcohol Rev
. 2023 Mar;
42(5):1104-1113.
PMID: 36908258
Introduction: Although there is momentum towards legalising adult recreational cannabis use worldwide, the extent of youth cannabis-related harm associated with legalisation is still uncertain. The current study aimed to assess...
5.
Benny A, McLay M, Callaghan R, Bates A, Olson R
BMC Psychiatry
. 2022 Aug;
22(1):543.
PMID: 35953787
Background: Individuals with psychiatric disorders (PD) have a high prevalence of tobacco use. Patients with PD also potentially receive substandard care in comparison to the general population. Previous research has...
6.
Callaghan R, Sanches M, Murray R, Konefal S, Maloney-Hall B, Kish S
Can J Psychiatry
. 2022 Jan;
67(8):616-625.
PMID: 35019734
Objective: Cannabis legalization in many jurisdictions worldwide has raised concerns that such legislation might increase the burden of transient and persistent psychotic illnesses in society. Our study aimed to address...
7.
Olson R, McLay M, Hamm J, Callaghan R
Curr Oncol
. 2021 Dec;
28(6):4953-4960.
PMID: 34898588
Background: Individuals with psychiatric disorders (PD) have a high prevalence of tobacco use. Therefore, we assessed the hazard of receiving a tobacco-related (TR) cancer diagnosis among individuals with PD. Methods:...
8.
Callaghan R, Sanches M, Vander Heiden J, Asbridge M, Stockwell T, MacDonald S, et al.
Drug Alcohol Depend
. 2021 Sep;
228:109008.
PMID: 34508959
Background: Worldwide momentum toward legalization of recreational cannabis use has raised a common concern that such policies might increase cannabis-impaired driving and consequent traffic-related harms, especially among youth. The current...
9.
Callaghan R, Vander Heiden J, Sanches M, Asbridge M, Hathaway A, Kish S
Addiction
. 2021 Jun;
116(12):3454-3462.
PMID: 34085338
Aims: Canada's 2018 Cannabis Act allows youth (age 12-17 years) to possess up to 5 g of dried cannabis (or equivalent) for personal consumption/sharing. This study assessed whether the Cannabis...
10.
Callaghan R, Sanches M, Kish S
Drug Alcohol Depend
. 2020 Sep;
217:108271.
PMID: 32977043
Background: In almost all of the literature examining the relation between cannabis use and cannabis-related harms, researchers have neglected to include quantity measures of cannabis use. The study aims to...